No previous study has examined anti-dermatophytic activity of COS in vivo. We used a guinea pig model to evaluate the clinical anti-dermatophytic efficacy of COS. Experimental treatments were applied for 14 d following 7 d of infection. Skin lesions were significantly improved during the first week of treatment by 5% COS, whose efficacy was superior to that of the positive control (clinical therapeutic agent FCZ).